{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-085894","form_type":"8-K","ticker":"REPL","cik":"0001737953","company_name":"Replimune Group, Inc.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.864070+00:00","generated_at":"2026-06-24T04:19:08.844454+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Replimune Q1 net loss $42.3M; CERPASS trial hits 180-patient enrollment target","bullets":["Cash & short-term investments $395.1M as of June 30, 2022, vs $395.7M at March 31, 2022.","Net loss $42.3M for Q1 ended June 30, 2022, up from $27.3M year-over-year; R&D expenses rose to $29.5M.","CERPASS registration trial for RP1 in CSCC reached target enrollment of 180 patients; primary data expected H1 2023.","First 75 patients enrolled in IGNYTE anti-PD1 failed melanoma cohort; data snapshot with 6-month follow-up expected Q4 2022.","Phase 2 development program for RP2/3 in SCCHN, HCC, and CRC expected to initiate Q1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-085894","json":"https://secwatch.observer/filing/0001104659-22-085894.json","markdown":"https://secwatch.observer/filing/0001104659-22-085894.md","text":"https://secwatch.observer/filing/0001104659-22-085894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922085894/0001104659-22-085894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922085894/tm2222536d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:19:08.844454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}